Infliximab induces increase in triglyceride levels in psoriatic arthritis patients. - Wikidata - awgldk - TriplyDB

Infliximab induces increase in triglyceride levels in psoriatic arthritis patients.

Infliximab induces increase in triglyceride levels in psoriatic arthritis patients.

http://www.wikidata.org/entity/Q35127601

about

Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management.Cardiovascular risk in patients with psoriatic arthritis.Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein function Effects of anti-TNF-α treatment on lipid profile in rheumatic diseases: an analytical cohort study.Infliximab reverses suppression of cholesterol efflux proteins by TNF-α: a possible mechanism for modulation of atherogenesis.Carotid intima-media thickness in spondyloarthritis patients.Lipid profile and anti-TNF-α use.Bevacizumab-induced oral mucositis in background of cutaneous plaque-type psoriasis.

P2860

Q35526652-A95E8F4E-F90D-43A7-8CFD-1B4111228BD1 Q35974962-232F925F-7416-4EDA-B157-440EC6DFB917 Q36681220-A775DCE1-63AD-47E2-96FD-DC10E72B44AE Q37405950-CA12DE57-C078-4A23-BB54-02CDC7D9469C Q37577348-F026236B-0B7E-4754-B497-12B69B90F3FB Q44925048-707B9FBD-D76D-44F0-B4DC-6CCA580C050F Q46195508-D1550D1B-19BE-41E0-A7C6-7E6141B6EBA0 Q48312769-42B2DCD5-8339-4FEB-AE93-926DCD87E16A

P2860

Infliximab induces increase in triglyceride levels in psoriatic arthritis patients.

http://www.wikidata.org/entity/Q35127601

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Infliximab induces increase in triglyceride levels in psoriatic arthritis patients.

@ast

Infliximab induces increase in triglyceride levels in psoriatic arthritis patients.

@en

type

label

Infliximab induces increase in triglyceride levels in psoriatic arthritis patients.

@ast

Infliximab induces increase in triglyceride levels in psoriatic arthritis patients.

@en

prefLabel

Infliximab induces increase in triglyceride levels in psoriatic arthritis patients.

@ast

Infliximab induces increase in triglyceride levels in psoriatic arthritis patients.

@en

P1433

Q35127601-E617DDBC-24E9-4FFB-9D7A-26E62AF060F2

P1476

Q35127601-35E9B86C-FF40-4C6F-BE04-36D0C2406136

P2093

Q35127601-2F5A6D90-3D62-4723-8B13-BB7A75404116

Q35127601-4658D795-278E-4A4E-8EA5-540EA8B17CA3

Q35127601-86EB4944-C647-4429-AC33-84201FD5DF1F

Q35127601-A2AD91C8-D6CC-4545-A7ED-4C5A4FC89DE6

Q35127601-D3F6DDD7-9D46-4CEF-A1ED-5CF2ECEF74D3

Q35127601-F3F6DCC0-6678-4CDB-A6B9-AC9C50CD96C9

P2860

Q35127601-2577F18D-DEDA-4542-BEC6-B873982B3B51

Q35127601-2A248915-D827-43F6-9A0A-23DE439398ED

Q35127601-50FF007C-898C-477E-AF9B-A77E57DFCBBE

Q35127601-6C9DA255-837C-4187-9BEF-C52A1AA07C57

Q35127601-6EDB7288-084D-47A2-BAD7-0730337D0B20

Q35127601-71A27609-C79E-4CD7-BFBF-C7F61BCEF204

Q35127601-780A63E1-612B-49C0-8C90-47E93E37A0CC

Q35127601-7CBB580B-853B-41A3-A58C-60B6BA740CC5

Q35127601-8DE96308-AA03-4E3E-B037-FE30BA3D3FCB

Q35127601-8E607A30-C973-481F-B35D-7E05C7B17361

P304

Q35127601-12B62D5A-9F00-4F04-8A66-91BF4046DFCE

P31

Q35127601-8C903047-9B85-4D1D-A388-0D8D7E128463

P356

Q35127601-44183F05-891C-43F0-A8F9-44FC48AF9688

P478

Q35127601-155098F5-7B9C-4266-9A82-E5E5F08BB7AC

P50

Q35127601-18793402-5BDD-444E-8AA1-65F26CC6212C

Q35127601-29273DB0-3521-450F-A8F3-89874C8F5EED

Q35127601-3D8B8DE2-C487-471B-A6DC-F78F00E7E05B

P577

Q35127601-F76C7D10-15F8-4AED-8B1F-D16395A759B2

P5875

Q35127601-03460199-2672-4610-89F4-B55E5C45E8EC

P698

Q35127601-A9A1DCAD-6DA2-4342-9F8F-0D87B9DF1A43

P921

Q35127601-E496F46F-C9F7-4DA9-A49A-9C1439DD4FAB

P932

Q35127601-C9599821-D4D3-48FF-9509-B60296661821

P356

P1433

Clinical and Developmental Immunology

P1476

Infliximab induces increase in triglyceride levels in psoriatic arthritis patients

@en

P2093

Ana C Medeiros

http://www.w3.org/2001/XMLSchema#string

Carla Gonçalves Saad

http://www.w3.org/2001/XMLSchema#string

Clovis A A Silva

http://www.w3.org/2001/XMLSchema#string

Jozélio F Carvalho

http://www.w3.org/2001/XMLSchema#string

Karla R Castro

http://www.w3.org/2001/XMLSchema#string

Licia Maria H Mota

http://www.w3.org/2001/XMLSchema#string

P2860

Atherosclerosis — An Inflammatory Disease

Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial.

Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.

Therapies for peripheral joint disease in psoriatic arthritis. A systematic review.

The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk.

Hypertriglyceridemia and cardiovascular risk reduction.

Comparison of current methods for high-density lipoprotein cholesterol quantitation.

Psoriatic arthritis. Historical background and epidemiology.

Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study.

Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis.

P304

352686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/352686

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51536105

http://www.w3.org/2001/XMLSchema#string

P698

21804855

http://www.w3.org/2001/XMLSchema#string

P921

P932

3143445

http://www.w3.org/2001/XMLSchema#string